Mephenaqualone
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| Drug class | Sedative; Hypnotic; Anxiolytic |
| ATC code |
|
| Pharmacokinetic data | |
| Onset of action | 20 minutes |
| Duration of action | ~4–10 hours |
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C22H18N2O2 |
| Molar mass | 342.398 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Mephenaqualone is an analogue of the sedative and hypnotic drug methaqualone which has been sold as a designer drug. It was reported in Germany in 2025 as a contributor to drug overdose cases but has otherwise been little studied. Anecdotal reports suggest it is considerably more potent than methaqualone with a potency similar to that of benzodiazepine derivatives, but no pharmacological data is available as yet. It is reported to have a dose of 0.7–0.8 mg or 2 mg orally and to produce sedative, hypnotic, euphoric, anxiolytic, and pro-sexual effects among others. Its onset is 20 minutes and its duration is approximately 4 to 10 hours.
Category:
- Drugs not assigned an ATC code